Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism
Public ClinicalTrials.gov record NCT01532414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Study identification
- NCT ID
- NCT01532414
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Repros Therapeutics Inc.
- Industry
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Interventions
- Androxal Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2012
- Primary completion
- Feb 28, 2013
- Completion
- Feb 28, 2013
- Last update posted
- May 26, 2015
2012 – 2013
United States locations
- U.S. sites
- 23
- U.S. states
- 11
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinical Research | Mobile | Alabama | 36608 | — |
| Baptist Health Center for Clinical Research | Little Rock | Arkansas | 72205 | — |
| SC Clinical Research | Garden Grove | California | 92844 | — |
| Mission Internal Medicine Group | Mission Viejo | California | 92691 | — |
| Rancho Cucamonga Clinical Trials | Rancho Cucamonga | California | 91730 | — |
| San Diego Sexual Medicine | San Diego | California | 92120 | — |
| West Coast Clinical Research | Tarzana | California | 91356 | — |
| Florida Fertility Institute | Clearwater | Florida | 33759 | — |
| Tampa Bay Medical Research | Clearwater | Florida | 33761 | — |
| ALL Medical Research | Cooper City | Florida | 33024 | — |
| Clinical Research of South Florida | Coral Gables | Florida | 33134 | — |
| Therafirst Medical Center | Fort Lauderdale | Florida | 33308 | — |
| Well Pharma Medical Research Group | Miami | Florida | 33143 | — |
| Phase One Solutions | Miami Gardens | Florida | 33169 | — |
| Meridien Research | St. Petersburg | Florida | 33709 | — |
| Central Kentucky Research Associates | Lexington | Kentucky | 40509 | — |
| Clinical Research Advantage | Henderson | Nevada | 89052 | — |
| Premier Urology Associates | Lawrenceville | New Jersey | 08648 | — |
| Rochester Clinical Research | Rochester | New York | 14609 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
| New Orleans Center for Clinical Research | Knoxville | Tennessee | 37920 | — |
| Lone Peak Family Medicine | Draper | Utah | 84020 | — |
| Granger Medical Clinic | West Valley City | Utah | 84120 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01532414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01532414 live on ClinicalTrials.gov.